Login

The mission to digitise, democratise, and decarbonise supply chains|Shereen Zarkani,Managing Partner and Head of Maersk Growth,Maersk Growth 00:10:00

Share On Facebook Share On Twitter

Previously the VP and Global Head of Maersk

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Results of a Pompe disease treatment trial are discussed by John Crowley | Bradley L. Campbell, PRESIDENT AND CHIEF EXECUTIVE OFFICER , AMICUS THERAPEUTICS, INC.
00:10:00
Graphic Packaging CEO Talks Sustainable Investments | Michael P. Doss - President and CEO, Director of Graphic Packaging Holding Co
00:10:00
Abel Travis, VP & Head of Fundamental Underwriters at AF Group, discusses the trajectory of future customers and strategies to meet their evolving needs.|Amund Tøftum is CEO in AF Gruppen
00:10:00
The Critical Role of Energy: Insights from Black Hills Corporation's CEO |Linn Evans, CEO , Black Hills Corporation
00:10:00
Corsa Coal CEO Thrilled by New Mine Opening | KEVIN M. HARRIGAN - PRESIDENT AND CHIEF EXECUTIVE OFFICER of Corsa Coal Corp
00:10:00
POET enhances AI capabilities through modules, including a new collaboration with Foxconn Interconnect Technology, a global optical technology leader.
00:10:00
Strategic Metals: Yukon Exploration and Investment Overview
00:10:00
The Benefits of Opening a Roth IRA for Your Child | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
Opportunities and Innovations in Financial Technology and Capital Markets.
00:10:00
How Quiet Luxury Can Elevate Your Social Media Presence
00:00:00
René C. Goehrum | Chairman, President & Chief Executive Officer, Biosyent Inc
00:00:00
Maher Masoud President and CEO, MaxCyte Inc

© 2026 Nehu